<DOC>
	<DOCNO>NCT00220324</DOCNO>
	<brief_summary>The purpose study investigate contraceptive efficacy , bleed pattern , safety SH D00342A . Subjects participate study treat oral contraceptive pill contain 0.03 mg ethinylestradiol 0.125 mg levonorgestrel .</brief_summary>
	<brief_title>Pearl Index Study With Low Dose Combined Oral Contraceptive</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany.Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Ethinyl Estradiol-Norgestrel Combination</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Healthy woman require contraception Pregnant lactate woman , history suspicion hormone dependent tumor condition forbid participation .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Contraception</keyword>
</DOC>